0.15Open0.15Pre Close0 Volume65 Open Interest55.00Strike Price0.00Turnover301.57%IV36.31%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.0192Delta0.0024Gamma574.13Leverage Ratio-0.1377Theta-0.0001Rho-11.02Eff Leverage0.0031Vega
AZZ Inc Stock Discussion
In reaction to earnings/guidance:
• $New Relic(NEWR.US)$ +3.8% (guidance), $American Airlines(AAL.US)$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC.(DICE.US)$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma(ALBO.US)$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
- $Consolidated Communications(CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $Voyager Therapeutics(VYGR.US)$ +12.2%: agrees to licensing option with $Novartis AG(NVS.US)$; Voyager receives $54 million upfront.
- $Aegon Ltd(AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $AZZ Inc(AZZ.US)$ +...
No comment yet